A. Vassault

发表

Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression

Alexandra Durr, Fanny Mochel, Anne Vassault, 2007, PloS one.

[Recommendations for expressing uncertainty of measurement of quantitative results in laboratory medicine].

A. Vassault, G. Férard, C. Giroud, 2007, Annales de biologie clinique.

New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria.

A. Munnich, N. Boddaert, A. Rötig, 2010, Mitochondrion.

Usefulness of Reference Materials in Calibration of Enzyme Activities

F. Schiele, J. Lessinger, I. Maire, 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia.

B. Lacour, J. Zingraff, P. Ureña, 1989, Kidney International.

[Interpretation and analysis of the requirements of the standard EN ISO 15189: 2012].

A. Vassault, 2013, Annales de biologie clinique.

Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma

C. Delacourt, A. Vassault, J. Blic, 1994, Allergy.

Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma

C. Delacourt, A. Vassault, J. Blic, 1994, Allergy.

Uremia-induced disturbances in hepatic carbohydrate metabolism: enhancement by sucrose feeding.

C. Jurkovitz, A. Vassault, M. Burtin, 1994, Metabolism: clinical and experimental.

Evaluation of GHb Assays in France by National Quality Control Surveys

P. Gillery, A. Vassault, G. Dumont, 1998, Diabetes Care.

[Post-examination phase: description and management control of the process].

F. Doucet-Populaire, A. Vassault, A. Perrin, 2012, Annales de biologie clinique.

Metabolic intermediates in lactic acidosis: compounds, samples and interpretation

A. Munnich, D. Rabier, P. Kamoun, 1996, Journal of Inherited Metabolic Disease.

Recommendation for the review of biological reference intervals in medical laboratories

J. Henny, M. Vaubourdolle, W. Huisman, 2016, Clinical chemistry and laboratory medicine.

Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics

Mario Plebani, Giuseppe Lippi, Pierangelo Bonini, 2009, Clinical chemistry and laboratory medicine.

Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories

Mario Plebani, Giuseppe Lippi, Pierangelo Bonini, 2008, Clinical chemistry and laboratory medicine.

Pediatric clinical chemistry: why is it different?

A. Vassault, R. Couderc, 2014, Clinical biochemistry.

Long‐Term Follow‐Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency

P. Laforêt, B. Eymard, A. Béhin, 2010, Clinical pharmacology and therapeutics.

Clinical aspects of mitochondrial disorders

A. Munnich, P. Rustin, A. Rötig, 1992, Journal of Inherited Metabolic Disease.

Tolerance to starvation in children on long-term total parenteral nutrition.

D. Rabier, O. Goulet, C. Ricour, 1997, Clinical nutrition.

Hepatic failure in disorders of oxidative phosphorylation with neonatal onset.

P. Rustin, D. Rabier, P. Parvy, 1991, The Journal of pediatrics.

Recommendations for the application and the follow-up of quality controls in medical biology laboratories.

R. Cartier, A. Vassault, J. Bouilloux, 2019, Annales de biologie clinique.

Genetic hypoglycaemia in infancy and childhood: Pathophysiology and diagnosis

D. Rabier, P. Kamoun, J. Saudubray, 2000, Journal of Inherited Metabolic Disease.

Multicenter evaluation of the hemolysis index in automated clinical chemistry systems

Mario Plebani, Giuseppe Lippi, Davide Giavarina, 2009, Clinical chemistry and laboratory medicine.

[Quality specifications and allowable standards for validation of methods used in clinical biochemistry].

J. Bienvenu, A. Vassault, D. Grafmeyer, 1999, Annales de biologie clinique.

Lactate, Pyruvate, Acetoacetate and 3-Hydroxybutyrate

A. Vassault, 2008 .

L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.

A. Servais, G. Deray, A. Vassault, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Successful Treatment of Severe Cardiomyopathy in Glycogen Storage Disease Type III With D,L-3-Hydroxybutyrate, Ketogenic and High-Protein Diet

D. Rabier, F. Petit, C. Ottolenghi, 2011, Pediatric Research.

The fasting test in paediatrics: Application to the diagnosis of pathological hypo- and hyperketotic states

A. Munnich, J. Saudubray, A. Lombès, 1990, European Journal of Pediatrics.

Muscle-Speciﬁc Loss of Apoptosis-Inducing Factor Leads to Mitochondrial Dysfunction, Skeletal Muscle Atrophy, and Dilated Cardiomyopathy

P. Bénit, G. Kroemer, P. Rustin, 2005 .

Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy

A. Munnich, M. Durán, N. Boddaert, 2010, Journal of Inherited Metabolic Disease.

Between-Country Comparability of Clinical Chemistry Results: An International Quality Assessment Survey of 17 Analytes in Six European Countries through Existing National Schemes

R. Jansen, C. D. de Verdier, A. D. De leenheer, 1993, Annals of clinical biochemistry.

Validation protocol of analytical hemostasis systems: measurement of anti-Xa activity of low-molecular-weight heparins.

A. Vassault, M. Dautzenberg, Y. Gourmelin, 1996, Clinical chemistry.

Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease

R. Barouki, J. Hanoune, B. Lacour, 1991, Hepatology.

An overview of serum mitochondrial aspartate aminotransferase (mAST) activity as a marker of chronic alcohol abuse.

S. Pol, P. Berthelot, A. Vassault, 1991, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[Protocol of metabolic investigations in hereditary metabolic diseases].

D. Rabier, P. Kamoun, J. Saudubray, 1994, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Continuous venovenous hemodialysis in a neonate model: a two-pump system.

P. Jouvet, N. Man, A. Vassault, 1998, Critical care medicine.

Approach to the patient with a fatty acid oxidation disorder.

A. Munnich, D. Rabier, J. Saudubray, 1992, Progress in clinical and biological research.

A new approach for clinical biological assay comparison and standardization: application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits.

B. Thirion, R. Sabatier, B. Pau, 1999, Clinical chemistry.

Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum.

A. Vassault, M. Pourci, M. Bailly, 1977, Clinical chemistry.

Serum Activity of Mitochondrial Aspartate Aminotransferase: A Sensitive Marker of Alcoholism With or Without Alcoholic Hepatitis

B. Lacour, N. Ferry, P. Berthelot, 1984, Hepatology.

Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit

B. Lacour, P. Berthelot, A. Vassault, 1986, Hepatology.

What’s new in metabolic and genetic hypoglycaemias: diagnosis and management

M. Polak, D. Rabier, J. Robert, 2008, European Journal of Pediatrics.

Suitability of control materials for determination of alpha-amylase activity.

A. Vassault, R. Rej, M. Bailly, 1981, Clinical chemistry.

Interassay calibration as a major contribution to the comparability of results in clinical enzymology.

F. Schiele, J. Lessinger, N. Tietz, 1998, Clinical biochemistry.

[Serum creatinine assay: results of a multicentric study with 16 analytical systems].

S. Costantini, A. Vassault, P. Baltassat, 1992, Annales de Biologie Clinique.

Muscle-Specific Loss of Apoptosis-Inducing Factor Leads to Mitochondrial Dysfunction, Skeletal Muscle Atrophy, and Dilated Cardiomyopathy

P. Bénit, G. Kroemer, P. Rustin, 2005, Molecular and Cellular Biology.

Atrophy , and Dilated Cardiomyopathy Mitochondrial Dysfunction , Skeletal Muscle Apoptosis-Inducing Factor Leads to Muscle-Specific Loss of

P. Bénit, G. Kroemer, P. Rustin, 2005 .

Hyperketotic states due to inherited defects of ketolysis.

J. Saudubray, A. Lombès, C. Jakobs, 1987, Enzyme.

[Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].

P. de Lonlay, D. Cheillan, G. Briand, 2012, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Mitochondria‐bound hexokinase as target for therapy of malignant gliomas

B. Dutrillaux, M. Poupon, S. Oudard, 1995, International journal of cancer.

[Evaluation according to the NCCLS protocol of the Kodak-Ektachem procedure applied to the estimation of glucose and urea in plasma (author's transl)].

L. Sebille, A. Vassault, M. Bailly, 1981, Annales de biologie clinique.

Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases

C. Junien, C. Sempoux, F. Brunelle, 2001, European Journal of Pediatrics.

Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis.

A Vassault, A. Munnich, P. Rustin, 1992, The Journal of pediatrics.

[Method selected for the determination of creatinine in plasma or serum. Choice of optimal conditions of measurement].

B. Lacour, A. Vassault, P. Baltassat, 1996, Annales de biologie clinique.

[Uncertainty of measurement].

A Vassault, C Giroud, A. Vassault, 2010, Annales de biologie clinique.

Validation of an enzyme calibrator--an IFCC guideline. International Federation of Clinical Chemistry.

T Kanno, N W Tietz, A Vassault, 1998, Clinical biochemistry.

Quality standards and internal quality control practices in medical laboratories: an IFCC global survey of member societies

I. Blasutig, R. Bais, A. Vassault, 2023, Clinical chemistry and laboratory medicine.

European Multicentre Evaluation of the ESAT 6660.

P. Bonini, R. Haeckel, A. Vassault, 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[Detection of Aspergillus antigen galactomannan using ELISA method: validation of the performances of the method for accreditation].

M. Rodier, A. Vassault, M. Arvier, 2013, Journal de mycologie medicale.

Immunochemical assays of serum proteins: a European external quality assessment survey and the effects of calibration procedures on interlaboratory agreement.

J. Bienvenu, J. Whicher, A. Vassault, 1990, Clinica chimica acta; international journal of clinical chemistry.

Glycohemoglobin assays evaluated in a large-scale quality-control survey.

P. Gillery, A. Vassault, D. Labbe, 1995, Clinical chemistry.

[Intrasplenic transplantation of hepatocytes in spf-ash mice with congenital ornithine transcarbamylase deficiency].

Y. Révillon, N. Brousse, D. Rabier, 1993, Chirurgie; memoires de l'Academie de chirurgie.

External quality assessment practices in medical laboratories: an IFCC global survey of member societies

I. Blasutig, R. Bais, A. Vassault, 2023, Clinical chemistry and laboratory medicine.

Long‐Term Follow‐Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency

P. Laforêt, B. Eymard, A. Béhin, 2010, Clinical pharmacology and therapeutics.

Production and certification of an enzyme reference material for pancreatic α-amylase (CRM 476)

F. Ceriotti, J. Lessinger, A. Vassault, 1996 .

A Multicentre European Evaluation of the Kodak EKTACHEM GLU/BUN Analyzer Using NCCLS Guidelines and Other Approaches

T. F. Woods, L. Sebille, D. Burnett, 1982, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.